Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-04A Long-term, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Flexible-Dose Brexpiprazole as Maintenance Treatment in Adolescents (13-17 Years Old) With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-03Transcranial Random Noise Stimulation in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients
-
CLINICAL_TRIALS study record update · 2026-02-03Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
-
CLINICAL_TRIALS study record update · 2026-02-03Magnetic Seizure Therapy for Schizophrenia - Trial
-
CLINICAL_TRIALS study record update · 2026-02-03Enhancing Recovery in Early Schizophrenia - a Multi-center, Two-arm, Double-blind, Randomized Phase II Trial Investigating Cannabidiol vs. Placebo as an add-on to an Individualized Antipsychotic Treatment
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-02Cognitive Enhancement for Persistent Negative Symptoms in Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-30Enhancing Rehabilitation for Veterans With Serious Mental Illness Via Biomarker-Informed Cognitive Training
-
CLINICAL_TRIALS study record update · 2026-01-29The Effect of Medication Education on Treatment Adherence and Side Effects in Psychiatric Inpatients: An Intervention Study
-
CLINICAL_TRIALS study record update · 2026-01-28Zyprexa® Relprevv™ Patient Care Program
-
CLINICAL_TRIALS study record update · 2026-01-28Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
-
CLINICAL_TRIALS study record update · 2026-01-27Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms
-
CLINICAL_TRIALS study record update · 2026-01-27Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE): a Community-Based Cognitive Remediation Trial
-
CLINICAL_TRIALS study record update · 2026-01-26THE EFFECT OF PSYCHOEDUCATION-BASED MOTIVATIONAL INTERVIEWING ON KNOWLEDGE ABOUT SCHIZOPHRENIA AND HOPE LEVELS IN PATIENTS DIAGNOSED WITH SCHIZOPHRENIA
-
CLINICAL_TRIALS study record update · 2026-01-23Dimensional and Developmental Approach to Psychotic Episodes in Children and Adolescents: Impact on Clinical Management
-
CLINICAL_TRIALS study record update · 2026-01-23European Long-acting Antipsychotics in Schizophrenia Trial-II
-
CLINICAL_TRIALS study record update · 2026-01-23Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-01-22Empirical Validation of a Cerebellar-cortical Hallucination Circuit
-
CLINICAL_TRIALS study record update · 2026-01-20A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-20Biomarkers in Clozapine-responding Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-16A Phase 4, Single-Arm, Open-Label Study to Evaluate the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Subjects With Tardive Dyskinesia
-
CLINICAL_TRIALS study record update · 2026-01-15A Phase 1, Open-label, Single-sequence Pharmacokinetic Trial to Assess the Effect of a Single Oral Dose of SEP-380135 on the Potential for Cytochrome P4502D6 Mediated Drug-drug Interactions in Healthy Adults
-
CLINICAL_TRIALS study record update · 2026-01-14A Multicenter, Uncontrolled, Open-label Trial to Evaluate the Tolerability, Safety, and Efficacy of Long-term Administration of SEP-363856 in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-14A 21-Week, Multicenter, Open-Label, Multiple-Dose Trial to Assess the Comparative Bioavailability of Olanzapine Prolonged-Release Suspension for Subcutaneous Administration (TV-44749) to Oral Olanzapine (European Reference) in Participants With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-14Intermittent Theta Burst Stimulation of the Precuneus for the Treatment of Resistant Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-14Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.